Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
40,376,179
-
Share change
-
+727,285
-
Total reported value
-
$151,810,870
-
Put/Call ratio
-
593%
-
Price per share
-
$3.76
-
Number of holders
-
85
-
Value change
-
+$3,564,383
-
Number of buys
-
55
-
Number of sells
-
31
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q2 2020
As of 30 Jun 2020,
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,376,179 shares.
The largest 10 holders included
NEA Management Company, LLC, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, Camber Capital Management LP, BlackRock Inc., EcoR1 Capital, LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, MORGAN STANLEY, and STATE STREET CORP.
This page lists
85
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.